aluates Reports

$ 0.0

Automative

Global Glioblastoma Multiforme Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-20V3145

Global Glioblastoma Multiforme Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Glioblastoma Multiforme Treatment Market Research Report 2025

Code: QYRE-Auto-20V3145

Report

September 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Roche

Merck

TEVA

Bristol–Myers Squibb

Sun Pharmaceutical

Arbor Pharmaceuticals

Glioblastoma Multiforme Treatment Market Size

The global market for Glioblastoma Multiforme Treatment was valued at US$ 650 million in the year 2024 and is projected to reach a revised size of US$ 1160 million by 2031, growing at a CAGR of 8.8% during the forecast period.

Glioblastoma Multiforme Treatment Market

Glioblastoma multiforme (GBM) is a fast-growing type of tumour of the brain or spinal cord. It is the most common type of primary malignant brain tumour in adults.

GBMs almost never spread outside of the brain, spine or central nervous system to other parts of the body. They are very challenging to treat because of their complex nature, which is why a great deal of research in the UK and around the world is focused on this tumour type.

This report aims to provide a comprehensive presentation of the global market for Glioblastoma Multiforme Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glioblastoma Multiforme Treatment.

The Glioblastoma Multiforme Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glioblastoma Multiforme Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Glioblastoma Multiforme Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Glioblastoma Multiforme Treatment Market Report

Report Metric	Details
Report Name	Glioblastoma Multiforme Treatment Market
Accounted market size in year	US$ 650 million
Forecasted market size in 2031	US$ 1160 million
CAGR	8.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Bevacizumab (Avastin) Carmustine (BiCNU) Temozolomide (Temodar and Temodal and Temcad)
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Merck, Teva, AbbVie, Inc, Bristol-Myers Squibb, Sun Pharmaceutical, Arbor Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glioblastoma Multiforme Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Glioblastoma Multiforme Treatment Market growing?

Ans: The Glioblastoma Multiforme Treatment Market witnessing a CAGR of 8.8% during the forecast period 2025-2031.

What is the Glioblastoma Multiforme Treatment Market size in 2031?

Ans: The Glioblastoma Multiforme Treatment Market size in 2031 will be US$ 1160 million.

Who are the main players in the Glioblastoma Multiforme Treatment Market report?

Ans: The main players in the Glioblastoma Multiforme Treatment Market are Roche, Merck, Teva, AbbVie, Inc, Bristol-Myers Squibb, Sun Pharmaceutical, Arbor Pharmaceuticals

What are the Application segmentation covered in the Glioblastoma Multiforme Treatment Market report?

Ans: The Applications covered in the Glioblastoma Multiforme Treatment Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Glioblastoma Multiforme Treatment Market report?

Ans: The Types covered in the Glioblastoma Multiforme Treatment Market report are Bevacizumab (Avastin), Carmustine (BiCNU), Temozolomide (Temodar and Temodal and Temcad)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Bevacizumab (Avastin)

1.2.3 Carmustine (BiCNU)

1.2.4 Temozolomide (Temodar and Temodal and Temcad)

1.3 Market by Application

1.3.1 Global Glioblastoma Multiforme Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Glioblastoma Multiforme Treatment Market Perspective (2020-2031)

2.2 Global Glioblastoma Multiforme Treatment Growth Trends by Region

2.2.1 Global Glioblastoma Multiforme Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Glioblastoma Multiforme Treatment Historic Market Size by Region (2020-2025)

2.2.3 Glioblastoma Multiforme Treatment Forecasted Market Size by Region (2026-2031)

2.3 Glioblastoma Multiforme Treatment Market Dynamics

2.3.1 Glioblastoma Multiforme Treatment Industry Trends

2.3.2 Glioblastoma Multiforme Treatment Market Drivers

2.3.3 Glioblastoma Multiforme Treatment Market Challenges

2.3.4 Glioblastoma Multiforme Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Glioblastoma Multiforme Treatment Players by Revenue

3.1.1 Global Top Glioblastoma Multiforme Treatment Players by Revenue (2020-2025)

3.1.2 Global Glioblastoma Multiforme Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Glioblastoma Multiforme Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Glioblastoma Multiforme Treatment Revenue

3.4 Global Glioblastoma Multiforme Treatment Market Concentration Ratio

3.4.1 Global Glioblastoma Multiforme Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Glioblastoma Multiforme Treatment Revenue in 2024

3.5 Global Key Players of Glioblastoma Multiforme Treatment Head office and Area Served

3.6 Global Key Players of Glioblastoma Multiforme Treatment, Product and Application

3.7 Global Key Players of Glioblastoma Multiforme Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Glioblastoma Multiforme Treatment Breakdown Data by Type

4.1 Global Glioblastoma Multiforme Treatment Historic Market Size by Type (2020-2025)

4.2 Global Glioblastoma Multiforme Treatment Forecasted Market Size by Type (2026-2031)

5 Glioblastoma Multiforme Treatment Breakdown Data by Application

5.1 Global Glioblastoma Multiforme Treatment Historic Market Size by Application (2020-2025)

5.2 Global Glioblastoma Multiforme Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Glioblastoma Multiforme Treatment Market Size (2020-2031)

6.2 North America Glioblastoma Multiforme Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Glioblastoma Multiforme Treatment Market Size by Country (2020-2025)

6.4 North America Glioblastoma Multiforme Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Glioblastoma Multiforme Treatment Market Size (2020-2031)

7.2 Europe Glioblastoma Multiforme Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Glioblastoma Multiforme Treatment Market Size by Country (2020-2025)

7.4 Europe Glioblastoma Multiforme Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Glioblastoma Multiforme Treatment Market Size (2020-2031)

8.2 Asia-Pacific Glioblastoma Multiforme Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Glioblastoma Multiforme Treatment Market Size (2020-2031)

9.2 Latin America Glioblastoma Multiforme Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Glioblastoma Multiforme Treatment Market Size by Country (2020-2025)

9.4 Latin America Glioblastoma Multiforme Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Glioblastoma Multiforme Treatment Market Size (2020-2031)

10.2 Middle East & Africa Glioblastoma Multiforme Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Glioblastoma Multiforme Treatment Introduction

11.1.4 Roche Revenue in Glioblastoma Multiforme Treatment Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Glioblastoma Multiforme Treatment Introduction

11.2.4 Merck Revenue in Glioblastoma Multiforme Treatment Business (2020-2025)

11.2.5 Merck Recent Development

11.3 Teva

11.3.1 Teva Company Details

11.3.2 Teva Business Overview

11.3.3 Teva Glioblastoma Multiforme Treatment Introduction

11.3.4 Teva Revenue in Glioblastoma Multiforme Treatment Business (2020-2025)

11.3.5 Teva Recent Development

11.4 AbbVie, Inc

11.4.1 AbbVie, Inc Company Details

11.4.2 AbbVie, Inc Business Overview

11.4.3 AbbVie, Inc Glioblastoma Multiforme Treatment Introduction

11.4.4 AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2020-2025)

11.4.5 AbbVie, Inc Recent Development

11.5 Bristol-Myers Squibb

11.5.1 Bristol-Myers Squibb Company Details

11.5.2 Bristol-Myers Squibb Business Overview

11.5.3 Bristol-Myers Squibb Glioblastoma Multiforme Treatment Introduction

11.5.4 Bristol-Myers Squibb Revenue in Glioblastoma Multiforme Treatment Business (2020-2025)

11.5.5 Bristol-Myers Squibb Recent Development

11.6 Sun Pharmaceutical

11.6.1 Sun Pharmaceutical Company Details

11.6.2 Sun Pharmaceutical Business Overview

11.6.3 Sun Pharmaceutical Glioblastoma Multiforme Treatment Introduction

11.6.4 Sun Pharmaceutical Revenue in Glioblastoma Multiforme Treatment Business (2020-2025)

11.6.5 Sun Pharmaceutical Recent Development

11.7 Arbor Pharmaceuticals

11.7.1 Arbor Pharmaceuticals Company Details

11.7.2 Arbor Pharmaceuticals Business Overview

11.7.3 Arbor Pharmaceuticals Glioblastoma Multiforme Treatment Introduction

11.7.4 Arbor Pharmaceuticals Revenue in Glioblastoma Multiforme Treatment Business (2020-2025)

11.7.5 Arbor Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Roche

Merck

TEVA

Bristol–Myers Squibb

Sun Pharmaceutical

Arbor Pharmaceuticals

List of Tables

Table 1. Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Bevacizumab (Avastin)

Table 3. Key Players of Carmustine (BiCNU)

Table 4. Key Players of Temozolomide (Temodar and Temodal and Temcad)

Table 5. Global Glioblastoma Multiforme Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Glioblastoma Multiforme Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Glioblastoma Multiforme Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Glioblastoma Multiforme Treatment Market Share by Region (2020-2025)

Table 9. Global Glioblastoma Multiforme Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Glioblastoma Multiforme Treatment Market Share by Region (2026-2031)

Table 11. Glioblastoma Multiforme Treatment Market Trends

Table 12. Glioblastoma Multiforme Treatment Market Drivers

Table 13. Glioblastoma Multiforme Treatment Market Challenges

Table 14. Glioblastoma Multiforme Treatment Market Restraints

Table 15. Global Glioblastoma Multiforme Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Glioblastoma Multiforme Treatment Market Share by Players (2020-2025)

Table 17. Global Top Glioblastoma Multiforme Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glioblastoma Multiforme Treatment as of 2024)

Table 18. Ranking of Global Top Glioblastoma Multiforme Treatment Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Glioblastoma Multiforme Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Glioblastoma Multiforme Treatment, Headquarters and Area Served

Table 21. Global Key Players of Glioblastoma Multiforme Treatment, Product and Application

Table 22. Global Key Players of Glioblastoma Multiforme Treatment, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Glioblastoma Multiforme Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Glioblastoma Multiforme Treatment Revenue Market Share by Type (2020-2025)

Table 26. Global Glioblastoma Multiforme Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Glioblastoma Multiforme Treatment Revenue Market Share by Type (2026-2031)

Table 28. Global Glioblastoma Multiforme Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Glioblastoma Multiforme Treatment Revenue Market Share by Application (2020-2025)

Table 30. Global Glioblastoma Multiforme Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Glioblastoma Multiforme Treatment Revenue Market Share by Application (2026-2031)

Table 32. North America Glioblastoma Multiforme Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Glioblastoma Multiforme Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Glioblastoma Multiforme Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Glioblastoma Multiforme Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Glioblastoma Multiforme Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Glioblastoma Multiforme Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Glioblastoma Multiforme Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Glioblastoma Multiforme Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Glioblastoma Multiforme Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Glioblastoma Multiforme Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Glioblastoma Multiforme Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Glioblastoma Multiforme Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Glioblastoma Multiforme Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. Roche Company Details

Table 48. Roche Business Overview

Table 49. Roche Glioblastoma Multiforme Treatment Product

Table 50. Roche Revenue in Glioblastoma Multiforme Treatment Business (2020-2025) & (US$ Million)

Table 51. Roche Recent Development

Table 52. Merck Company Details

Table 53. Merck Business Overview

Table 54. Merck Glioblastoma Multiforme Treatment Product

Table 55. Merck Revenue in Glioblastoma Multiforme Treatment Business (2020-2025) & (US$ Million)

Table 56. Merck Recent Development

Table 57. Teva Company Details

Table 58. Teva Business Overview

Table 59. Teva Glioblastoma Multiforme Treatment Product

Table 60. Teva Revenue in Glioblastoma Multiforme Treatment Business (2020-2025) & (US$ Million)

Table 61. Teva Recent Development

Table 62. AbbVie, Inc Company Details

Table 63. AbbVie, Inc Business Overview

Table 64. AbbVie, Inc Glioblastoma Multiforme Treatment Product

Table 65. AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2020-2025) & (US$ Million)

Table 66. AbbVie, Inc Recent Development

Table 67. Bristol-Myers Squibb Company Details

Table 68. Bristol-Myers Squibb Business Overview

Table 69. Bristol-Myers Squibb Glioblastoma Multiforme Treatment Product

Table 70. Bristol-Myers Squibb Revenue in Glioblastoma Multiforme Treatment Business (2020-2025) & (US$ Million)

Table 71. Bristol-Myers Squibb Recent Development

Table 72. Sun Pharmaceutical Company Details

Table 73. Sun Pharmaceutical Business Overview

Table 74. Sun Pharmaceutical Glioblastoma Multiforme Treatment Product

Table 75. Sun Pharmaceutical Revenue in Glioblastoma Multiforme Treatment Business (2020-2025) & (US$ Million)

Table 76. Sun Pharmaceutical Recent Development

Table 77. Arbor Pharmaceuticals Company Details

Table 78. Arbor Pharmaceuticals Business Overview

Table 79. Arbor Pharmaceuticals Glioblastoma Multiforme Treatment Product

Table 80. Arbor Pharmaceuticals Revenue in Glioblastoma Multiforme Treatment Business (2020-2025) & (US$ Million)

Table 81. Arbor Pharmaceuticals Recent Development

Table 82. Research Programs/Design for This Report

Table 83. Key Data Information from Secondary Sources

Table 84. Key Data Information from Primary Sources

Table 85. Authors List of This Report

List of Figures

Figure 1. Glioblastoma Multiforme Treatment Picture

Figure 2. Global Glioblastoma Multiforme Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Glioblastoma Multiforme Treatment Market Share by Type: 2024 VS 2031

Figure 4. Bevacizumab (Avastin) Features

Figure 5. Carmustine (BiCNU) Features

Figure 6. Temozolomide (Temodar and Temodal and Temcad) Features

Figure 7. Global Glioblastoma Multiforme Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Glioblastoma Multiforme Treatment Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Others Case Studies

Figure 12. Glioblastoma Multiforme Treatment Report Years Considered

Figure 13. Global Glioblastoma Multiforme Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Glioblastoma Multiforme Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Glioblastoma Multiforme Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global Glioblastoma Multiforme Treatment Market Share by Players in 2024

Figure 17. Global Top Glioblastoma Multiforme Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glioblastoma Multiforme Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Glioblastoma Multiforme Treatment Revenue in 2024

Figure 19. North America Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Glioblastoma Multiforme Treatment Market Share by Country (2020-2031)

Figure 21. United States Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Glioblastoma Multiforme Treatment Market Share by Country (2020-2031)

Figure 25. Germany Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Glioblastoma Multiforme Treatment Market Share by Region (2020-2031)

Figure 33. China Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Glioblastoma Multiforme Treatment Market Share by Country (2020-2031)

Figure 41. Mexico Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Glioblastoma Multiforme Treatment Market Share by Country (2020-2031)

Figure 45. Turkey Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Glioblastoma Multiforme Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Roche Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2020-2025)

Figure 49. Merck Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2020-2025)

Figure 50. Teva Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2020-2025)

Figure 51. AbbVie, Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2020-2025)

Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2020-2025)

Figure 53. Sun Pharmaceutical Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2020-2025)

Figure 54. Arbor Pharmaceuticals Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2020-2025)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Adult Malignant Glioma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Therapy for Brain Cancer Market Research Report 2025

Global Glioblastoma Treatment Drugs Market Insights Forecast to 2030

Global Brain Cancer Targeted Drug Market Research Report 2025

Low Grade Glioma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Malignant Glioma Therapeutics Market Research Report 2024

Global Glioma Treatment Market Research Report 2025

Global Brain Tumor Therapeutics Market Research Report 2024

Brain Cancer Treatment Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Brain Tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Brain and Central Nervous System Cancer Treatments Market Research Report 2024

Global Brain Tumor Diagnosis and Therapeutics Market Insights Forecast to 2030

Tumor Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sarcoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anaplastic Astrocytoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030

Brain Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligodendroglioma Treatment Market Research Report 2024

Global Neuroblastoma Treatment Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions